Annexon (ANNX) Preferred Dividend Payments (2019 - 2020)
Annexon's (ANNX) quarterly Preferred Dividend Payments came in at $145000.0 in Q3 2020, down 48.4% year-on-year from $281000.0 in Q4 2019, and down 97.7% quarter-over-quarter from $6.3 million in Q2 2020.
Annexon (ANNX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Annexon's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $145000.0 for Q3 2020.
- On a quarterly basis, Preferred Dividend Payments fell 48.4% year-over-year to $145000.0 in Q3 2020; TTM through Dec 2020 was $6.7 million, a N/A change from a year earlier, with the FY2020 full-year figure at $705000.0, down 35.62% from the prior year.
- Preferred Dividend Payments eased to $145000.0 in Q3 2020 per ANNX's latest filing, from $6.3 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $6.3 million in Q2 2020 and bottomed at $145000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 145,000.00 |
| Jun 30, 2020 | 6.30 Mn |
| Mar 31, 2020 | 279,000.00 |
| Dec 31, 2019 | 280,000.00 |
| Sep 30, 2019 | 281,000.00 |
| Jun 30, 2019 | 272,000.00 |